II Consenso de la Sociedad Chilena de Endocrinología y Diabetes sobre resistencia a la insulina
Author
dc.contributor.author
Pollak, Felipe
Author
dc.contributor.author
Araya Quintanilla, Verónica
Author
dc.contributor.author
Lanas Montecinos, Alejandra
Author
dc.contributor.author
Sapunar, Jorge
Author
dc.contributor.author
Carrasco Naranjo, Fernando
Author
dc.contributor.author
Codner Dujovne, Ethel
Author
dc.contributor.author
Durruty Alfonso, Pilar
Author
dc.contributor.author
Liberman Guendelman, Claudio
Author
dc.contributor.author
López Stewart, Gloria
Author
dc.contributor.author
Poniachik Teller, Jaime
Author
dc.contributor.author
Sir Petermann, Teresa
Author
dc.contributor.author
Soto, Néstor
Admission date
dc.date.accessioned
2015-09-15T14:56:13Z
Available date
dc.date.available
2015-09-15T14:56:13Z
Publication date
dc.date.issued
2015
Cita de ítem
dc.identifier.citation
Revista médica de Chile. Volumen: 143 Número: 5 Páginas: 627-636
en_US
Identifier
dc.identifier.other
DOI: 10.4067/S0034-98872015000500012
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/133640
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Insulin resistance is a prevalent condition commonly associated with unhealthy lifestyles. It affects several metabolic pathways, increasing risk of abnormalities at different organ levels. Thus, diverse medical specialties should be involved in its diagnosis and treatment. With the purpose of unifying criteria about this condition, a scientific-based consensus was elaborated. A questionnaire including the most important topics such as cardio-metabolic risk, non-alcoholic fatty liver disease and polycystic ovary syndrome, was designed and sent to national experts. When no agreement among them was achieved, the Delphi methodology was applied. The main conclusions reached are that clinical findings are critical for the diagnosis of insulin resistance, not being necessary blood testing. Acquisition of a healthy lifestyle is the most important therapeutic tool. Insulin-sensitizing drugs should be prescribed to individuals at high risk of disease according to clinically validated outcomes. There are specific recommendations for pregnant women, children, adolescents and older people.